Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
10
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Simeonidis Harry | President | 1 | $0 | $0 | 2022-10-10 |
| Sakiris Spiro Kevin | ChiefFinancial Officer | 7 | $60.7K | $0 | 2022-10-10 |
| Hurd Jonathan Scott | Director | 1 | $0 | $0 | 2022-10-10 |
| Boyages Steven Constantine | Interim CEO and Chairperson | 1 | $0 | $0 | 2022-10-10 |
| Margelis George | Director | 1 | $0 | $0 | 2022-10-10 |
| TOWERS CHRISTOPHER | Director | 2 | $5.5K | $0 | 2022-10-10 |
| FISHER LAWRENCE B | Director | 1 | $0 | $0 | 2022-10-10 |
| Life Science Biosensor Diagnostics Pty Ltd | Other | 33 | $0 | $6.89M | 2022-02-17 |
| Parmakellis Tom | Director | 4 | $18.5K | $0 | 2021-12-30 |
| Gavrilenko Victoria | Director | 1 | $296 | $0 | 2021-03-02 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Sakiris Spiro Kevin | Chief Financial Officer | A Award | 2022-10-10 | 2022-10-12 | 75,000 | — | $0 | 125,228 | SEC↗ |
| Boyages Steven Constantine | Interim CEO and Chairperson | A Award | 2022-10-10 | 2022-10-12 | 75,000 | — | $0 | 75,000 | SEC↗ |
| FISHER LAWRENCE B | Director | A Award | 2022-10-10 | 2022-10-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Margelis George | Director | A Award | 2022-10-10 | 2022-10-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TOWERS CHRISTOPHER | Director | A Award | 2022-10-10 | 2022-10-12 | 15,000 | — | $0 | 15,800 | SEC↗ |
| Hurd Jonathan Scott | Director | A Award | 2022-10-10 | 2022-10-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Simeonidis Harry | President | A Award | 2022-10-10 | 2022-10-12 | 80,000 | — | $0 | 80,600 | SEC↗ |
| Sakiris Spiro Kevin | Chief Financial Officer | P Buy | 2022-06-22 | 2022-06-24 | 5,000 | $0.65 | $3.3K | 50,228 | SEC↗ |
| Sakiris Spiro Kevin | ChiefFinancial Officer | P Buy | 2022-06-17 | 2022-06-22 | 15,970 | $0.61 | $9.7K | 45,228 | SEC↗ |
| Life Science Biosensor Diagnos | Other | S Sale | 2022-02-17 | 2022-02-22 | 576,028 | $0.51 | $293.8K | 1,081,804 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2022-02-16 | 2022-02-18 | 100,000 | $0.63 | $63.0K | 1,657,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2022-02-15 | 2022-02-17 | 100,000 | $0.68 | $68.0K | 1,757,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2022-02-14 | 2022-02-17 | 100,000 | $0.70 | $70.0K | 1,857,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2022-02-11 | 2022-02-17 | 100,000 | $0.75 | $75.0K | 1,957,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2022-02-10 | 2022-02-15 | 100,000 | $0.84 | $84.0K | 2,057,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2022-02-09 | 2022-02-11 | 100,000 | $0.86 | $86.0K | 2,157,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2022-02-08 | 2022-02-10 | 100,000 | $0.89 | $89.0K | 2,257,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2022-02-02 | 2022-02-08 | 100,000 | $0.92 | $92.0K | 2,357,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2022-01-31 | 2022-02-03 | 100,000 | $0.90 | $90.0K | 2,457,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2022-01-28 | 2022-02-01 | 100,000 | $0.92 | $92.0K | 2,557,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2022-01-27 | 2022-02-01 | 100,000 | $1.00 | $100.0K | 2,657,832 | SEC↗ |
| Parmakellis Tom | Director | P Buy | 2021-12-30 | 2022-01-03 | 4,500 | $1.55 | $7.0K | 9,300 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-12-17 | 2021-12-21 | 200,000 | $1.49 | $298.0K | 2,757,832 | SEC↗ |
| Parmakellis Tom | Director | P Buy | 2021-12-16 | 2021-12-20 | 2,800 | $1.69 | $4.7K | 4,800 | SEC↗ |
| Sakiris Spiro Kevin | ChiefFinancial Officer | P Buy | 2021-12-06 | 2021-12-07 | 10,000 | $1.70 | $17.0K | 29,258 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-11-30 | 2021-12-03 | 250,000 | $1.87 | $467.5K | 2,957,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-11-29 | 2021-12-01 | 100,000 | $1.69 | $169.0K | 3,207,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-11-24 | 2021-11-29 | 100,000 | $1.64 | $164.0K | 3,307,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-11-09 | 2021-11-12 | 300,000 | $2.02 | $606.0K | 3,407,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-10-21 | 2021-10-25 | 248,416 | $2.26 | $561.4K | 3,707,832 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-10-20 | 2021-10-22 | 24,209 | $2.25 | $54.5K | 3,956,248 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-10-19 | 2021-10-21 | 16,326 | $2.25 | $36.7K | 3,980,457 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-10-14 | 2021-10-18 | 100,726 | $2.18 | $219.6K | 3,996,783 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-10-13 | 2021-10-15 | 58,739 | $2.25 | $132.2K | 4,097,509 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-10-12 | 2021-10-14 | 100,000 | $2.13 | $213.0K | 4,156,248 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-10-08 | 2021-10-12 | 200,000 | $2.30 | $460.0K | 4,256,248 | SEC↗ |
| Parmakellis Tom | Director | P Buy | 2021-09-28 | 2021-09-30 | 1,000 | $2.40 | $2.4K | 2,000 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-09-28 | 2021-09-30 | 200,000 | $2.48 | $496.0K | 4,456,248 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-09-24 | 2021-09-28 | 200,000 | $2.66 | $532.0K | 4,656,248 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-09-23 | 2021-09-27 | 100,000 | $2.77 | $277.0K | 4,856,248 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-09-22 | 2021-09-24 | 100,000 | $2.80 | $280.0K | 4,956,248 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-09-21 | 2021-09-23 | 100,000 | $2.83 | $283.0K | 5,056,248 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-09-20 | 2021-09-22 | 100,000 | $2.90 | $290.0K | 5,156,248 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | S Sale | 2021-09-17 | 2021-09-22 | 45,152 | $3.29 | $148.6K | 5,256,248 | SEC↗ |
| Parmakellis Tom | Director | P Buy | 2021-06-21 | 2021-06-28 | 1,000 | $4.44 | $4.4K | 1,000 | SEC↗ |
| Sakiris Spiro Kevin | Chief Financial Officer | P Buy | 2021-05-19 | 2021-05-21 | 10,000 | $3.07 | $30.7K | 16,258 | SEC↗ |
| Gavrilenko Victoria | Director | P Buy | 2021-03-02 | 2021-03-03 | 37 | $8.09 | $296 | 37 | SEC↗ |
| TOWERS CHRISTOPHER | Director | P Buy | 2021-02-24 | 2021-02-25 | 800 | $6.84 | $5.5K | 800 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | X Exercise deriv | 2021-01-18 | 2021-01-21 | 117,647 | — | $0 | 0 | SEC↗ |
| Life Science Biosensor Diagnos | 10% Owner | X Exercise | 2021-01-18 | 2021-01-21 | 117,647 | — | $0 | 5,786,694 | SEC↗ |
| Chief Financial Officer | X Exercise deriv | 2021-01-04 | 2021-02-16 | 1,479 | — | $0 | 0 | SEC↗ | |
| Chief Financial Officer | X Exercise | 2021-01-04 | 2021-02-16 | 1,479 | — | $0 | 6,258 | SEC↗ |